Newsroom
December 20, 2021
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
DURHAM, NC – December 20, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing,…
November 18, 2021
Bioventus to Expand Operations and Manufacturing in Memphis
MEMPHIS, TN – November 18, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
November 15, 2021
Bioventus Announces Chief Financial Officer Transition Plan
DURHAM, NC – November 15, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations…
November 9, 2021
Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance
DURHAM, NC – November 9, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
November 1, 2021
Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs
DURHAM, NC – November 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
October 29, 2021
Bioventus Completes the Acquisition of Misonix
DURHAM, NC – October 29, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
October 27, 2021
Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
DURHAM, NC – October 27, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
October 26, 2021
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
DURHAM, NC and FARMINGDALE, NY – October 26, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
October 18, 2021
Bioventus Inc. and Misonix, Inc. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
DURHAM, NC and FARMINGDALE, NY – October 18, 2021 –Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an…
September 20, 2021
DUROLANE Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
DURHAM, NC – September 20, 2021 – Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced…
